Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

Affiliations

• ¹ Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.
• ² Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK.
• ³ Centre for Evaluation and Methods, Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ⁴ Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK; National Institute for Health Research and Cancer Research UK Southampton Experimental Cancer Medicine Centre, Wessex Investigational Sciences Hub Laboratory, Southampton General Hospital, Southampton, UK.
• ⁵ Department of Haematology, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle Upon Tyne, UK.
• ⁶ Department of Haematology, University Hospitals of Leicester National Health Service Trust, Leicester, UK; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
• ⁷ Department of Haematology, Norfolk and Norwich University Hospitals National Health Service Foundation Trust, Norwich, UK.
• ⁸ Department of Oncology, Bedford Hospital, Bedford, UK.
• ⁹ School of Medicine, University of Nottingham, Nottingham University Hospitals National Health Service Trust, Nottingham, UK.
• ¹⁰ Department of Clinical Haematology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
• ¹¹ Department of Oncology, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
• ¹² Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK. Electronic address: s.h.lim@soton.ac.uk.